Xiangyang Ge

2.9k total citations
22 papers, 166 citations indexed

About

Xiangyang Ge is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiangyang Ge has authored 22 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 8 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Xiangyang Ge's work include SARS-CoV-2 and COVID-19 Research (15 papers), SARS-CoV-2 detection and testing (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Xiangyang Ge is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), SARS-CoV-2 detection and testing (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Xiangyang Ge collaborates with scholars based in China, United States and United Kingdom. Xiangyang Ge's co-authors include Bin Ju, Zheng Zhang, Bing Zhou, Qing Fan, Huimin Guo, Lin Cheng, Shuo Song, Miao Wang, Haiyan Wang and Lei Liu and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Journal of Virology.

In The Last Decade

Xiangyang Ge

17 papers receiving 165 citations

Peers

Xiangyang Ge

ASZ

RNMI

IMMUN

Ruxia Ding China

Wilhelm Furnon United Kingdom

Jelle van Schooten Netherlands

Ayae Nishiyama Japan

Ren Yang China

Kirthi K. Kutumbaka United States

Siân E. Jossi United Kingdom

Christopher Z. Lien United States

Krithika Muthuraman Canada

Mitchell D. Ramuta United States

Ruxia Ding China

Xiangyang Ge

140 ×1.1

31 ×0.6

21 ×0.9

ASZ

19 ×0.9

RNMI

19 ×0.9

IMMUN

Citations per year, relative to Xiangyang Ge Xiangyang Ge (= 1×) peers Ruxia Ding

Countries citing papers authored by Xiangyang Ge

Since Specialization

Citations

This map shows the geographic impact of Xiangyang Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Ge more than expected).

Fields of papers citing papers by Xiangyang Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Ge. The network helps show where Xiangyang Ge may publish in the future.

Co-authorship network of co-authors of Xiangyang Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Ge. A scholar is included among the top collaborators of Xiangyang Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Ge. Xiangyang Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Qing, Congcong Liu, Huimin Guo, et al.. (2025). A distinctive IGHV3-66 SARS-CoV-2 neutralizing antibody elicited by primary infection with an Omicron variant. Structure. 33(7). 1165–1177.e6.

Gui, Qi, Haiyan Wang, Congcong Liu, et al.. (2025). NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants. Virology Journal. 22(1). 45–45.

Gui, Qi, Congcong Liu, Bing Zhou, et al.. (2025). Structure and function of a pair of non-competing monoclonal antibodies against Langya henipavirus attachment glycoprotein. Cell Reports. 44(10). 116407–116407.

Wang, Miao, Congcong Liu, Qing Fan, et al.. (2025). Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies. The Journal of Immunology. 214(2). 278–289.

Zhou, Bing, Qi Gui, Congcong Liu, et al.. (2025). Structure and function of an unusual R452-dependent monoclonal antibody against SARS-CoV-2. Journal of Virology. 99(5). e0184424–e0184424. 1 indexed citations

Yang, Haonan, Huimin Guo, Aojie Wang, et al.. (2024). Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants. Nature Communications. 15(1). 7715–7715. 16 indexed citations

Li, Dapeng, Haiyan Wang, Jiamin Feng, et al.. (2024). Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological study. Emerging Microbes & Infections. 13(1). 2356153–2356153. 6 indexed citations

Hu, Yan, Congcong Liu, Yuxiao Li, et al.. (2024). The characterization and structural basis of a human broadly binding antibody to HBV core protein. Journal of Virology. 99(1). e0169424–e0169424.

Su, Jingwen, et al.. (2024). Maslinic acid alleviates alcoholic liver injury in mice and regulates intestinal microbiota via the gut–liver axis. Journal of the Science of Food and Agriculture. 104(13). 7928–7938. 5 indexed citations

10.

Cheng, Zhiwei, Yilin Ren, Jing Mu, et al.. (2023). Akkermansia muciniphila Protects Against Antibiotic-Associated Diarrhea in Mice. Probiotics and Antimicrobial Proteins. 16(4). 1190–1204. 17 indexed citations

11.

Guo, Huimin, Jie Jiang, Xiangyang Ge, et al.. (2023). Additional mutations based on Omicron BA.2.75 mediate its further evasion from broadly neutralizing antibodies. iScience. 26(4). 106283–106283. 8 indexed citations

12.

Ju, Bin, Qing Fan, Congcong Liu, et al.. (2023). Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination. Cell Reports. 42(6). 112532–112532. 14 indexed citations

13.

Zhou, Bing, Shuo Song, Huimin Guo, et al.. (2022). A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS‐CoV‐2 variants including BA.1 and BA.2 in vaccinated mice. Journal of Medical Virology. 94(8). 3992–3997. 6 indexed citations

14.

Zhou, Bing, Lin Cheng, Shuo Song, et al.. (2022). Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron. Virology Journal. 19(1). 96–96. 8 indexed citations

15.

Wang, Miao, Qing Fan, Bing Zhou, et al.. (2022). A key F27I substitution within HCDR1 facilitates the rapid maturation of P2C-1F11-like neutralizing antibodies in a SARS-CoV-2-infected donor. Cell Reports. 40(11). 111335–111335. 4 indexed citations

16.

Guo, Huimin, Qing Fan, Shuo Song, et al.. (2022). Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization. Journal of Clinical Virology. 150-151. 105162–105162. 6 indexed citations

17.

Song, Shuo, Bing Zhou, Lin Cheng, et al.. (2022). Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice. Virology Journal. 19(1). 2–2. 12 indexed citations

18.

Ju, Bin, Qing Fan, Miao Wang, et al.. (2022). Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections. Nature Communications. 13(1). 7120–7120. 30 indexed citations

19.

Cheng, Lin, Shuo Song, Bing Zhou, et al.. (2021). Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes. Virology Journal. 18(1). 87–87. 23 indexed citations

20.

Ge, Xiangyang, et al.. (1990). [Studies on antigens of human lung adenocarcinoma with McAb LC-1].. PubMed. 23(2). 233–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact